echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Bayer Group announces 2020 fiscal year results

    Bayer Group announces 2020 fiscal year results

    • Last Update: 2021-07-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


















    For example, in order to achieve the goal of "making development benefit more low-income people", the group launched the "Better Farms, Better Lives" project
    .
    Through this project, the group has provided modern crop protection products to 1.
    5 million small farmers
    .
    By cooperating with the Challenge Project, Bayer also provides support for family planning and reproductive health solutions for African women and girls
    .


    The establishment of the external "sustainable development committee" marked another important development
    .
    In addition, "Achieving the Sustainable Development Goals" has been included in the assessment of long-term variable remuneration for members of the management committee and other managers
    .
    From 2021, the weight of this indicator in the performance appraisal is 20%, highlighting the importance of these sustainable development goals to the group
    .


    Outlook: Bayer has set a sales growth target (adjusted by exchange rate and asset portfolio)


    Bayer released its exchange rate-adjusted Group Outlook for the year 2021: After exchange rate and asset portfolio adjustments, Bayer expects sales to reach between 42 billion and 43 billion euros, in line with a growth rate of approximately 3%
    .
    The group expects an EBITDA margin, excluding special items, to be about 27%
    .
    This is equivalent to approximately 11.
    2 billion to 11.
    5 billion euros before interest, taxes, depreciation and amortization excluding special items
    .
    Bayer plans to have a core earnings per share of approximately 6.
    10 to 6.
    30 euros
    .
    The group's free cash flow is expected to be between minus 3 billion and minus 4 billion euros
    .
    This amount takes into account the negative impact of approximately 8 billion euros paid to resolve the lawsuit
    .
    Bayer also predicts that as of December 31, 2021, the group's net financial debt will be approximately 36 billion euros to 37 billion euros
    .


    Based on the exchange rate on December 31, 2020, Bayer expects that its sales in 2021 will reach approximately 41 billion euros, with an EBITDA margin excluding special items of about 26% and an EBITDA margin excluding special items.
    The profit is about 10.
    5 billion to 10.
    8 billion euros, and the core earnings per share are between 5.
    60 and 5.
    80 euros
    .
    On this basis, Bayer expects free cash flow to be negative 3 billion to negative 4 billion euros, and net financial debt to 35 to 36 billion euros
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.